CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction

Molecular Endocrinology

Volumn 22, Issue 1, 2008, Pages 33-46

  Ji, Ho Suh ^a   Shong, Minho ^b   Choi, Hueng Sik ^a   Lee, Keesook ^a  

^a Chonnam National University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CR6 INTERACTING FACTOR 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HISTONE DEACETYLASE 4; MESSENGER RNA; NUCLEAR PROTEIN; PROSTATE SPECIFIC ANTIGEN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN DETERMINATION; REPRESSOR GENE; TRANSACTIVATION;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; CHROMATIN IMMUNOPRECIPITATION; COS CELLS; FLOW CYTOMETRY; HISTONE DEACETYLASES; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, CONFOCAL; MODELS, GENETIC; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TWO-HYBRID SYSTEM TECHNIQUES;

EID: 38049013817     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0194     Document Type: Article

References (48)

1. Chung HK, Yi YW, Jung NC, Kim D, Suh JM, Kim H, Park KC, Song JH, Kim DW, Hwang ES, Yoon SH, Bae YS, Kim JM, Bae I, Shong M 2003 CR6-interacting factor 1 interacts with Gadd45 family proteins and modulates the cell cycle. J Biol Chem 278:28079-28088
2. Park KC, Song KH, Chung HK, Kim H, Kim DW, Song JH, Hwang ES, Jung HS, Park SH, Bae I, Lee IK, Choi HS, Shong M 2005 CR6-interacting factor 1 interacts with orphan nuclear receptor Nur77 and inhibits its transactivation. Mol Endocrinol 19:12-24
3. Oh NS, Yoon SH, Lee WK, Choi JY, Min DS, Bae YS 2007 Phosphorylation of CKBBP2/CRIF1 by protein kinase CKII promotes cell proliferation. Gene 386:147-153
4. Gelmann EP 2002 Molecular biology of the androgen receptor. J Clin Oncol 20:3001-3015
5. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y 1987 The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362
6. Lasnitzki I, Mizuno T 1980 Prostatic induction: interaction of epithelium and mesenchyme from normal wild-type mice and androgen-insensitive mice with testicular feminization. J Endocrinol 85:423-428
7. Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C 2002 Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues. Proc Natl Acad Sci USA 99:13498-13503
8. Donjacour AA, Cunha GR 1998 The effect of androgen deprivation on branching morphogenesis in the mouse prostate. Dev Biol 128:1-14
9. Heinlein CA, Chang C 2004 Androgen receptor in prostate cancer. Endocr Rev 25:276-308
10. Sadi MV, Walsh PC, Barrack ER 1991 Immunohistochemical study of androgen receptors in metastatic prostate cancer. Cancer 67:3057-3064
11. Chodak GW, Kranc DM, Puy LA, Takeda H, Johnson K, Chang C 1992 Nuclear localization of androgen receptor in heterogeneous samples of normal, hyperplastic and neoplastic human prostate. J Urol 147:798-803
12. de Winter JAR, Janssen PJA, Sleddens HMEB, Verleun-Mooijman MCT, Trapman J Brinkmann AO, Santerse AB, Schroeder FH, van der Kwast TH 1994 Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 144:735-746
13. Gao J, Isaacs JT 1998 Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells. Cancer Res 58:3299-3306
14. Zegarra-Moro OL, Schmidt LJ, Huang H, Tindall DJ 2002 Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. Cancer Res 62:1008-1013
15. Haag P, Bektic J, Bartsch G, Klocker H, Eder IE 2005 Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. J Steroid Biochem Mol Biol 96:251-258
16. Liao X, Tang S, Thrasher JB, Griebling TL, Li B 2005 Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer. Mol Cancer Ther 4:505-515
17. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
18. Langley E, Zhou ZX, Wilson EM 1995 Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 270:29983-29990
19. 2-terminal and steroid-binding domains. J Biol Chem 268:19004-19012
20. Truss M, Bartsch J, Schelbert A, Hache RJ, Beato M 1995 Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J 14:1737-1751
21. Bannister AJ, Kouzarides T 1996 The CBP co-activator is a histone acetyltransferase. Nature 384:641-643
22. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y 1996 The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959
23. Imhof A, Yang X-J, Ogryzko VV, Nakatani Y, Wolffe AP, Ge H 1997 Acetylation of general transcription factors by histone acetyltransferases. Curr Biol 7:689-692
24. Heinzel T, Lavinsky RM, Mullen TM, Soderstrom M, Laherty CD, Torchia J, Yang WM, Brard G, Ngo SD, Davie JR, Seto E, Eisenman RN, Rose DW, Glass CK, Rosenfeld MG. 1997 A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387:43-48
25. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM 1997 Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380
26. Gobinet J, Auzou G, Nicolas JC, Sultan C, Jalaguier S 2001 Characterization of the interaction between androgen receptor and a new transcriptional inhibitor, SHP. Biochemistry 40:15369-15377
27. Loy CJ, Sim KS, Young EL 2003 Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions. Proc Natl Acad Sci USA 100:4562-4567
28. Zhang Y, Yang Y, Yeh S, Chang C 2004 ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation. Mol Cell Biol 24:1044-1057
29. Dedhar S, Rennie PS, Shago M, Hagesteijn CY, Yang H, Filmus J, Hawley RG, Bruchovsky N, Cheng H, Matusik RJ, Giguere V 1994 Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367:480-483
30. Moilanen AM, Poukka H, Karvonen U, Hakli M, Janne OA, Palvimo JJ 1998 Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol Cell Biol 18:5128-5139
31. Jeong BC, Hong CY, Chattopadhyay S, Park JH, Gong EY, Kim HJ, Chun SY, Lee K 2004 Androgen receptor corepressor-19 kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase. Mol Endocrinol 18:13-25
32. Hong CY, Gong EY, Kim Kim K, Suh JH, Ko HM, Lee HJ, Choi HS, Lee K 2005 Modulation of the expression and transactivation of androgen receptor by the basic helix-loop-helix transcription factor Pod-1 through recruitment of histone deacetylase 1. Mol Endocrinol 19:2245-2257
33. de Launoit Y, Veilleux R, Dufour M, Simard J, Labrie F 1991 Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells. Cancer Res 51:5165-5170
34. Chen S, Xu Y, Yuan X, Bubley GJ, Balk SP 2006 Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1. Proc Natl Acad Sci USA 103:15969-15974
35. Reutens AT, Fu M, Wang C, Albanese C, McPhaul MJ, Sun Z, Balk SP, Janne OA, Palvimo JJ, Pestell RG 2001 Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol 15:797-811
36. Zwijsen RM, Buckle RS, Hijmans EM, Loomans CJ, Bernards R 1998 Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1. Genes Dev 12:3488-3498
37. Markus SM, Taneja SS, Logan SK, Li W, Ha S, Hittelman AB, Rogatsky I, Garabedian MJ 2002 Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol Biol Cell 13:670-682
38. Aarnisalo P, Palvimo JJ, Janne OA 1998 CREB-binding protein in androgen receptor-mediated signalling. Proc Natl Acad Sci USA 95:2122-2127
39. Frønsdal K, Engedal N, Slagsvold T, Saatcioglu F 1998 CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J Biol Chem 273:31853-31859
40. Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B 1999 The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol 19:6085-6097
41. Ma H, Hong H, Huang SM, Irvine RA, Webb P, Kushner PJ, Coetzee GA, Stallcup MR 1999 Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins. Mol Cell Biol 19:6164-6173
42. Bevan CL, Hoare S, Claessens F, Heery DM, Parker MG 1999 The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 19:8383-8392
43. Yeh S, Chang C 1996 Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 93:5517-5521
44. Gao T, Brantley K, Bolu E, McPhaul MJ 1999 RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand-dependent fashion, but functions only weakly as a coactivator in cotransfection assays. Mol Endocrinol 13:1645-1656
45. Lee YS, Kim HJ, Lee HJ, Lee JW, Chun SY, Ko SK, Lee K 2002 Activating signal cointegrator 1 is highly expressed in murine testicular Leydig cells and enhances the ligand-dependent transactivation of androgen receptor. Biol Reprod 67:1580-1587
46. Chattopadhyay S, Gong EY, Hwang M, Park E, Lee HJ, Hong CY, Choi SH, Cheong JH, Kwon HB, Lee K 2006 The CCAAT enhancer-binding protein-α negatively regulates the transactivation of androgen receptor in prostate cancer cells. Mol Endocrinol 20:984-995
47. Lee SK, Anzick SL, Choi JE, Bubendorf L, Guan XY, Jung YK, Kallioniemi OP, Kononen J, Trent JM, Azorsa D, Jhun BH, Cheong JH, Lee YC, Meltzer PS, Lee JW 1999 A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. J Biol Chem 274:34283-34293
48. Hong CY, Park JH, Seo KH, Kim JM, Im SY, Lee JW, Choi HS, Lee K 2003 Expression of MIS in the testis is downregulated by TNF-through the negative regulation of SF-1 transactivation by NF-κB. Mol Cell Biol 23:6000-6012